Health Care/Hospital
DiscGenics Announces Research Collaboration with the U.S. Department of Veterans Affairs for Tissue-Engineered Discs with Discogenic Cells
Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding SALT LAKE CITY, Nov. 9, 2023 /PRNewswire/ -- DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function...
2023-11-09 08:15
1981
Dr. Jinzi J. Wu Presents at the 10th International Workshop on HBV Cure 2023
HANGZHOU and SHAOXING, China, Nov. 9, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that Dr.Jinzi J. Wu, Founder, Chairman and CEO of Ascletis was invited to attend and have a presentation at the 10th International Workshop on HBV Cure 2023 held atBoston, Unit...
2023-11-09 08:10
4609
Telix to Present at Jefferies London Healthcare Conference 2023
MELBOURNE, Australia, Nov. 9, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that DrChristian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies London Healthcare Conference 2023. The presentation will take place o...
2023-11-09 04:51
1774
Frost & Sullivan Honors Leading Organizations with Prestigious Industry Awards at the 2023 Best Practices Awards Ceremony
Sixteen Companies Awarded Excellence in Best Practices by Frost & Sullivan for Best-in-Class Performance KUALA LUMPUR, Malaysia, Nov. 9, 2023 /PRNewswire/ -- The 2023 Frost & Sullivan Best Practices Awards Ceremony took place at the St. Regis Hotel in Kuala Lumpur, Malaysia, bringing together com...
2023-11-09 00:08
1899
Allgenesis Announces Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema at American Academy of Ophthalmology
TAIPEI, Nov. 8, 2023 /PRNewswire/ -- * AG-73305 was found to be safe and tolerable with no severe adverse effects (SAEs) after a single intravitreal injection of doses of 0.5, 1, 2, and 4 mg in DME patients. * Data combining all 4 cohorts showed mean improvement in Best Corrected Visual Acc...
2023-11-08 23:23
1919
Seoul National University Bundang Hospital (SNUBH) Secures Prestigious GHA Accreditation, Reinforcing Its Position as a Premier Global Medical Travel Destination
PALM BEACH GARDENS, Fla., Nov. 8, 2023 /PRNewswire/ -- Seoul National University Bundang Hospital (SNUBH), one of South Korea's most prestigious healthcare institutions, is delighted to announce that it has achieved a second consecutive term of Accreditation with Excellence fromGlobal Healthcare ...
2023-11-08 19:00
1898
The 2023 Asia Health and Life Sciences Innovation and Cooperation Summit Delivered Insights on the Future of Healthcare
SINGAPORE, Nov. 8, 2023 /PRNewswire/ -- The 2023 Asia Health and Life Sciences Innovation and Cooperation Summit (AHLSICS), hosted by ASK Health Asia and the SingHealth Duke-NUS Global Health Institute (SDGHI), in collaboration with the World Economic Forum, successfully concluded in Singapore on 1s...
2023-11-08 14:30
2521
Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region
MELBOURNE, Australia, Nov. 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement withDenmark-based WIIK Pharma ApS (Wiik Pharma) for the distribution of Telix's investigational prostate cancer imaging agent, Illuc...
2023-11-08 13:00
1702
Simulare Medical Launches the Alveolar Bone Graft Simulator
ABG Simulator New Addition to Further Support Cleft Reconstructive Surgical Training TAIPEI, Nov. 8, 2023 /PRNewswire/ -- Simulare Medical, a division of Smile Train Inc. (New York) announces the launch of the Alveolar Bone Graft (ABG) simulator, the latest high-fidelity surgical item in its gro...
2023-11-08 10:00
2119
Docquity Expands Digitized Patient Access Programs To Enhance Healthcare Outcomes in Thailand
* After a successful pilot in the Philippines, five DocquityCare Patient Access Programs (PAPs)have been launched in Thailand * DocquityCare PAP will support more than 100 hospitals and 250 healthcare professionals (HCPs) to improve patient care for those with cancer and other life-threatenin...
2023-11-08 10:00
2335
Antengene to Host 2023 R&D Day and Discuss Key Data with KOLs
* During the event, Antengene will review promising data of its R&D pipeline, includingATG-031 (anti-CD24 monoclonal antibody), ATG-101 (PD-L1/4-1BB bispecific antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), ATG-037 (CD73 inhibitor), and ATG-008 (dual mTORC1/2 inhibitor). * The vir...
2023-11-08 08:30
1895
Flagship Pioneering Expands into Asia-Pacific Region, with Regional Hub in Singapore
André Andonian Joins Flagship to Lead APAC Region SINGAPORE, Nov. 8, 2023 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced its expansion into theAsia-Pacific region, with the opening of a regional hub inSingapore. This follows the company's expansion into ...
2023-11-08 06:00
1958
Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
* ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations, representing the first innovation in endocrine therapy in nearly 20 years. * ESR1 mutations are present in up to 40% of ER+, HER2- advance...
2023-11-08 02:01
1757
Discovery Life Sciences Announces New CEO
Greg Herrema to Spearhead Next Phase of Global Biospecimen and Biomarker Company's Expansion HUNTSVILLE, Ala., Nov. 7, 2023 /PRNewswire/ -- Discovery Life Sciences, the Biospecimen and Biomarker Specialists, announced today the appointment ofGreg Herrema as its new chief executive officer. A lea...
2023-11-07 23:01
2056
Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, With No Distribution to Other Organs
* Company's eTurna™ delivery platform ensures unprecedented precision, safety * In-vivo biodistribution of mRNA into dermal cells, tissues shows high transfection efficiency, gene expression * Data presented at ASDS Annual Meeting MOUNTAIN VIEW, Calif., Nov. 7, 2023 /PRNewswire/ -- Turn Biot...
2023-11-07 21:30
2711
Registration for the 7th IFPA Conference 2024 now open
STOCKHOLM, Nov. 7, 2023 /PRNewswire/ -- IFPA (International Federation of Psoriasis Associations) is thrilled to announce the 7th IFPA Conference (former World Psoriasis & Psoriatic Arthritis Conference), set to take place fromJune 27 to 29, 2024, in the vibrant city of Stockholm, Sweden. Establi...
2023-11-07 18:00
1983
Antech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory
Antech to offer UK veterinary professionals a complete and flexible diagnostics portfolio spanning reference labs, in-house diagnostics, imaging and software WARWICK, England, 7 Nov. 2023 /PRNewswire/ -- Antech, the full-service veterinary diagnostics business that is part of the Science & Diagno...
2023-11-07 15:30
1826
2023 World Laureates Association Prize winners awarded in Shanghai
SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- The five winners of the 2023 World Laureates Association Prize (WLA Prize) received their awards for their ground-breaking achievements in computer science or mathematics and life science or medicine onNov. 6 at the opening ceremony of the 6th WLA Forum held...
2023-11-07 09:49
513
KN026 was Granted Breakthrough Therapy Designation by CDE
SUZHOU, China, Nov. 7, 2023 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced, that the Center for Drug Evaluation (CDE) ofChina's National Medical Products Administration (NMPA) granted a Breakthrough Therapy d...
2023-11-07 08:51
1728
Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia
* A survey conducted in seven Asian markets, including Japan, revealed that respondents, on average, spent 6.8 years on their fertility journey, with 3.6 years dedicated to trying to conceive naturally.1,2 * In Indonesia, Japan, Korea, Singapore, and Vietnam, at least 70 percent of respondent...
2023-11-07 08:15
1265
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 294 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 286 media titles]
2024-11-15 15:25
Most Read
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
2024-11-13 09:00
6744
Sobot Introduces its All-in-One Solution at GITEX Global 2024
2024-11-12 11:00
5924
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5699